The emerging treatment of the medication represents a exciting advance in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide275483.xzblogs.com/82433632/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment